missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ SARS CoV-2 3CL Protease Substrate, Rh110-conjugated
Click to view available options
Quantity:
200 μg
Unit Size:
200µg
Description
The sequence is derived from the SARS CoV-2 3CLpro. Release of Rhodamine 110 can be monitored with excitation and emission wavelengths of 485 nm and 535 nm, respectively. Conditions will need to be optimized for each specific application. We recommend an initial substrate concentration of 4-20 μM.
Specifications
Specifications
| For Use With (Application) | Bioactivity |
| Formulation | 4 mM in DMSO |
| Gene ID (Entrez) | 43740578 |
| Molecular Weight (g/mol) | M.W.-theoretical: 1096.3 Da |
| Quantity | 200 μg |
| Storage Requirements | Protect from light. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 60 months from date of receipt, -20°C to -70°C as supplied. 3 months, -20°C to -70°C under sterile conditions after opening. |
| Gene Alias | 3 CL Proteinase, 3 C-like main protease, 3 CL-Mpro, COVID-19, M Proteinase, Main Protease, Mpro |
| Purity or Quality Grade | >95%, by HPLC. 1096.6 Da |
| Protein | SARS-CoV-2 3 CL Protease |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction